Woo, Patrick C Y <br/><br/>
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.  [electronic resource] 

 -  Vaccine  Oct 2005 
 - 4959-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2005.05.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antibodies, Viral--blood<br/>Bacterial Vaccines--administration & dosage<br/>Escherichia coli Proteins<br/>Immunization Schedule<br/>Immunization, Secondary<br/>Immunoglobulin G--blood<br/>Injections, Intramuscular<br/>Injections, Intraperitoneal<br/>Interferon-gamma--analysis<br/>Interleukin-4--analysis<br/>Male<br/>Membrane Glycoproteins--administration & dosage<br/>Mice<br/>Mice, Inbred BALB C<br/>Models, Animal<br/>Neutralization Tests<br/>Severe acute respiratory syndrome-related coronavirus--immunology<br/>Severe Acute Respiratory Syndrome--prevention & control<br/>Spike Glycoprotein, Coronavirus<br/>Vaccines, DNA--administration & dosage<br/>Vaccines, Synthetic--administration & dosage<br/>Viral Envelope Proteins--administration & dosage